The Latest in Lymphoma & Plasma Cell Disorders

CAR T-cell therapies difficult to compare

February 16, 2019

Adding palbociclib upped responses in previously treated MCL

February 15, 2019

Lymphoma & Plasma Cell Disorders

EC approves BV plus AVD for Hodgkin lymphoma

February 15, 2019

Lymphoma & Plasma Cell Disorders

Few DLBCL patients benefit from nivolumab

February 14, 2019

Lymphoma & Plasma Cell Disorders

Targeted triplet shows potential for B-cell cancers

February 14, 2019

FDA approves daratumumab split-dosing regimen in MM

February 13, 2019

Lymphoma & Plasma Cell Disorders

Anthracyclines, bendamustine are options for grade 3A follicular lymphoma

February 11, 2019

Ibrutinib-MTX-rituximab combo shows promise in CNS lymphoma

February 11, 2019

Daratumumab disappoints in non-Hodgkin lymphoma trial

February 11, 2019

BCL expression intensity key in distinguishing FL lesions

February 10, 2019

Trial supports less aggressive myeloma treatment

February 8, 2019

Combo appears to overcome aggressive L-NN-MCL

February 8, 2019

Lymphoma & Plasma Cell Disorders

Increased risk of second cancers in mycosis fungoides

February 8, 2019

FDA: 246 new reports on breast implant-associated lymphoma

February 7, 2019

Lymphoma & Plasma Cell Disorders

Cobomarsen shows early promise for treating ATLL

February 7, 2019

Lymphoma & Plasma Cell Disorders